According to the latest report by IMARC Group, titled “Research Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global research antibodies market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the global research antibodies market to grow at a CAGR of around 7% during the forecast period (2021-2026). Antibodies refer to glycoproteins that act as crucial components of the immune system found in body fluids. They circulate in the blood and provide protection against antigens or foreign substances like viruses and bacteria. Research antibodies are used as fundamental detection tools for biological research due to their specific recognition and affinity for antigens. Owing to these factors, these antibodies play an essential role in recognizing specific cellular components and the development of routine diagnostic medical tests in the research field.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/research-antibodies-market/requestsample
A significant rise in the prevalence of cancer is primarily influencing the demand for research antibodies to detect key cancer targets and use them in several applications. Besides this, as stem cells help in maintaining and repairing the tissues, they are extensively utilized in developmental biology, disease modeling research, cell therapy studies, and drug development screening. This is further catalyzing the demand for high-quality antibodies for the characterization of different stem cells. Moreover, the widespread of the coronavirus disease has augmented the need for quick, potential treatments to halt viral transmission. This is encouraging the adoption of research antibodies to gain insight into the immune system response for viral infection and prepare an effective vaccine. Moreover, the increasing investments in the R&D activities to formulate innovative research antibodies are anticipated to further propel the global market in the coming years.
Explore Full Report with TOC & List of Figure: https://bit.ly/3dHQWNi
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abcam Plc
- Agilent Technologies Inc.
- Dickinson and Company
- Bio-Rad Laboratories Inc.
- Cell Signalling Technology Inc.
- Hoffmann La Roche Ltd.
- Lonza Group AG
- Merck KGaA
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc
The report has segmented the market on the basis of region, type, technology, source, application and end user.
Breakup by Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
Breakup by Technology:
- Western Blotting
- Flow Cytometry
Breakup by Source:
- Mouse Antibodies
- Rabbit Antibodies
- Goat Antibodies
Breakup by Application:
- Infectious Diseases
- Stem Cells
Breakup by End User:
- Academic and Research Institutes
- Contract Research Organizations
- Pharmaceutical and Biotechnology Companies
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Latest Research Reports by IMARC Group: